Tab conjugated estogen premarin 0 point 625 mg,Tab Methotrexate 5 mg,MDI Asthalin 100 mcg inhaler,A
Indian Air Force
Bid Publish Date
09-Jan-2026, 12:45 pm
Bid End Date
19-Jan-2026, 1:00 pm
EMD
₹1,301
Location
Progress
Quantity
10212
Category
Tab Lorlatinib 25 mg
Bid Type
Two Packet Bid
A tender has been published for Indian Army Tab Lorlatinib 25 mg, Tab Trametinib 0 point 5mg, Cap Dabrafenib 75mg, Tab Venetoclax 100 mg, Tab Relugolix 120mg, EXEMESTANE 25mg Tab, GAMMA TOCOTRIENOL DELTA TOCOTRIENOL 400 MG Tab, AFATINIB 40MG Tab, Inj Denosumab 60 mg ml, Suppository mesalamine 500mg in WEST DELHI, DELHI. Quantity: 10212 by. Submission Deadline: 19-01-2026 13: 00: 00. Check eligibility and apply.
Indian Air Force
Indian Army
HYDERABAD, TELANGANA
Indian Army
JAISALMER, RAJASTHAN
Indian Army
CHAMBA, HIMACHAL PRADESH
Border Security Force (bsf)
WEST GARO HILLS, MEGHALAYA
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Tab Lorlatinib 25 mg | AS PER boq att | 900 | no | prabhatbarua | 30 |
| 2 | Tab Trametinib 0 point 5mg | AS PER boq att | 1,260 | no | prabhatbarua | 30 |
| 3 | Cap Dabrafenib 75mg | AS PER boq att | 1,232 | no | prabhatbarua | 30 |
| 4 | Tab Venetoclax 100 mg | AS PER boq att | 756 | no | prabhatbarua | 30 |
| 5 | Tab Relugolix 120mg | AS PER boq att | 180 | no | prabhatbarua | 30 |
| 6 | EXEMESTANE 25mg Tab | AS PER boq att | 787 | no | prabhatbarua | 30 |
| 7 | GAMMA TOCOTRIENOL DELTA TOCOTRIENOL 400 MG Tab | AS PER boq att | 1,260 | no | prabhatbarua | 30 |
| 8 | AFATINIB 40MG Tab | AS PER boq att | 180 | no | prabhatbarua | 30 |
| 9 | Inj Denosumab 60 mg ml | AS PER boq att | 492 | pfs | prabhatbarua | 30 |
| 10 | Suppository mesalamine 500mg | AS PER boq att | 3,165 | no | prabhatbarua | 30 |
Discover companies most likely to bid on this tender
Indian Army
Indian Army
📍 UDHAMPUR, JAMMU & KASHMIR
Indian Army
📍 KOLKATA, WEST BENGAL
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS